首页> 外文期刊>Cell death & disease. >Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of γH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation
【24h】

Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of γH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation

机译:吩噻嗪类药物在人肺癌细胞中的化学致敏作用:γH2AX的分辨率受损和氧化应激增加会引起与溶酶体扩增和强烈空泡相关的凋亡

获取原文
           

摘要

Chemotherapy resistance poses severe limitations on the efficacy of anti-cancer medications. Recently, the notion of using novel combinations of ‘old’ drugs for new indications has garnered significant interest. The potential of using phenothiazines as chemosensitizers has been suggested earlier but so far our understanding of their molecular targets remains scant. The current study was designed to better define phenothiazine-sensitive cellular processes in relation to chemosensitivity. We found that phenothiazines shared the ability to delay γH2AX resolution in DNA-damaged human lung cancer cells. Accordingly, cells co-treated with chemotherapy and phenothiazines underwent protracted cell-cycle arrest followed by checkpoint escape that led to abnormal mitoses, secondary arrest and/or a form of apoptosis associated with increased endogenous oxidative stress and intense vacuolation. We provide evidence implicating lysosomal dysfunction as a key component of cell death in phenothiazine co-treated cells, which also exhibited more typical hallmarks of apoptosis including the activation of both caspase-dependent and -independent pathways. Finally, we demonstrated that vacuolation in phenothiazine co-treated cells could be reduced by ROS scavengers or the vacuolar ATPase inhibitor bafilomycin, leading to increased cell viability. Our data highlight the potential benefit of using phenothiazines as chemosensitizers in tumors that acquire molecular alterations rendering them insensitive to caspase-mediated apoptosis.. ? 2011 Macmillan Publishers Limited
机译:化疗耐药性严重限制了抗癌药物的疗效。最近,将“旧”药物的新颖组合用于新适应症的想法引起了广泛关注。较早提出使用吩噻嗪作为化学增敏剂的潜力,但到目前为止,我们对其分子靶标的了解仍然很少。当前的研究旨在更好地定义与化学敏感性有关的吩噻嗪敏感性细胞过程。我们发现吩噻嗪在​​DNA损伤的人类肺癌细胞中具有延迟γH2AX分解的能力。因此,用化学疗法和吩噻嗪共同处理的细胞经历了延长的细胞周期停滞,随后发生检查点逃逸,这导致异常的有丝分裂,继发停滞和/或与内源性氧化应激增加和强烈空泡相关的凋亡形式。我们提供的证据表明溶酶体功能障碍是吩噻嗪共处理细胞中细胞死亡的关键组成部分,后者还表现出更典型的凋亡标志,包括激活caspase依赖性和非依赖性途径。最后,我们证明了通过ROS清除剂或液泡ATPase抑制剂巴氟霉素可以减少吩噻嗪共处理细胞的空泡化,从而提高细胞活力。我们的数据强调了在肿瘤中使用吩噻嗪作为化学增敏剂的潜在好处,该药物获得分子改变,使其对caspase介导的细胞凋亡不敏感。 2011 Macmillan Publishers Limited

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号